Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05664113 · ClinicalTrials.gov registry record · Phase 1
Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).
A Phase 1 study of Gastro-Intestinal Disorder, sponsored by St. Jude Children's Research Hospital.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05664113 is a Phase 1 study of Gastro-Intestinal Disorder that is actively recruiting participants, run by St. Jude Children's Research Hospital. The registered enrollment target is 10 participants, below the 204-participant average among 6 other Gastro-Intestinal Disorder trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05664113, a Phase 1 study of Gastro-Intestinal Disorder, is actively recruiting participants, sponsored by St. Jude Children's Research Hospital.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The study participant is being asked to take part in this clinical trial, a type of research study, because the participant has Gastrointestinal (GI) symptoms following a Hematopoietic Cell Transplant (HCT). Primary Objective * To determine the safety and feasibility of FMT for treating a GvHD of the gut following HCT. * To determine the safety and feasibility of FMT for treating HCT induced gut dysfunction. Secondary Objectives * To assess the potential efficacy of FMT for treating a GvHD of the gut following HCT. * To assess the potential efficacy of FMT for treating HCT induced gut dysfunction.
Conditions Studied
Interventions
- DRUG Fecal microbiota transplant (FMT)
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-07-07 |
| Est. Completion | 2028-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05664113
The ClinicalTrials.gov registry entry for NCT05664113 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 204-participant average among 6 other Gastro-Intestinal Disorder trials with a reported enrollment target (95% lower). The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastro-Intestinal Disorder appearing as the primary indexed condition, and to 1 intervention - of which Fecal microbiota transplant (FMT) is the first listed.
NCT05664113 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT05664113 about?
NCT05664113 is a clinical study titled "Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).". The study participant is being asked to take part in this clinical trial, a type of research study, because the participant has Gastrointestinal (GI) symptoms following a Hematopoietic Cell Transplant (HCT). Primary Objective * To determine the safety and feasibility of FMT for treating a GvHD of ...
What is the current status of trial NCT05664113?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2025-07-07. Estimated completion is 2028-12-31.
What conditions does trial NCT05664113 study?
This clinical trial studies the following conditions: Gastro-Intestinal Disorder.
What interventions are being tested in trial NCT05664113?
The interventions under investigation include: Fecal microbiota transplant (FMT) (DRUG).
Who is sponsoring clinical trial NCT05664113?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05664113 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastro-Intestinal Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Gut-Brain Study
ACTIVE NOT RECRUITING · Phase 1
-
Gastroparesis Registry 4
RECRUITING
-
MTT for Children With ASD Who Have Gastrointestinal Disorders
ACTIVE NOT RECRUITING · Phase 2
-
Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders
ACTIVE NOT RECRUITING · Phase 2
-
Biological Sample Repository for Gastrointestinal Disorders
ACTIVE NOT RECRUITING
-
Minimal Risk Registry of Endoscopic Image and Pathology Correlation for Fujiflim
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.